Pfizer Inc. (New York, NY) received...

Pfizer Inc. (New York, NY) received marketing authorization from the European Commission for as well-as; not only-but also; not only-but; not alone-but oral and intravenous formulations of Vfend (voriconazole) for the treatment of potentially fatal fungal infections.
FDA granted marketing approval of Elan Corporation, plc's (Dublin, Ireland) Avinza (morphine sulfate extended-release) capsules for the once-daily treatment of chronic, moderate-to-severe pain in patients who require continuous, around-the-clock therapy for an lengthen outed period of time.
Arixtra (fondaparinux sodium), a synthetic pay with an abatement being codeveloped by